Nisa Investment Advisors’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-473
Closed -$15.8K 3094
2024
Q3
$15.8K Buy
473
+436
+1,178% +$15K ﹤0.01% 1981
2024
Q2
$1K Buy
37
+29
+363% +$572 ﹤0.01% 2515
2024
Q1
$173 Buy
+8
New +$174 ﹤0.01% 2665

Nisa Investment Advisors's LBPH Position: Q4 2024 in Review

Nisa Investment Advisors sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 473 shares — an estimated $15.8K sold.

Nisa Investment Advisors first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $15.8K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Nisa Investment Advisors reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 473 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $15.8K.
  • Nisa Investment Advisors first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Nisa Investment Advisors's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $15.8K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Nisa Investment Advisors's 13F filing for Q4 2024, filed 17 Jan 2025.